San Raffaele Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
San Raffaele Hospital takes part in 7 sessions at ESMO 2026 in Madrid. Its program spans blood and genitourinary cancers, from fixed-duration versus continuous first-line treatment in chronic lymphocytic leukaemia to secondary central nervous system lymphoma. In bladder cancer, it covers organ preservation in high-risk non-muscle-invasive disease and phase 3 results adding nivolumab to chemotherapy for muscle-invasive disease.
| Organization | ESMO 2026 Attendance |
|---|---|
San Raffaele Hospital Milan, Italy | |
Private research and teaching hospital in Milan, Italy, recognised by the Italian state as a scientific research institute. | Abstract Fri Oct 23 13:40–13:50 Talk Fri Oct 23 16:35–16:55 Time-limited or continuous treatment at first line: Which and for whom? Haematological malignancies Satellite Fri Oct 23 19:00–19:40 Abstract Sat Oct 24 11:00–11:10 Abstract Sat Oct 24 11:20–11:25 Talk Sat Oct 24 15:15–15:30 Squamous carcinoma Genitourinary cancers Talk Mon Oct 26 14:45–15:05 Presentation by Expert Haematological malignancies |
Instantly find 20 buyers from San Raffaele Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction